Clinical Clarity
We combine advanced AI with deep health data and genomic expertise to deliver clinical-grade interpretation, neonatal screening, and population health intelligence — at a fraction of legacy costs.
Forged in World-Class Genomics. Built for the World.
Genomatis was founded by a professional whose career was shaped by some of the most ambitious genomic medicine and public health programmes in the world — including the UK's Genomic Medicine Service, where he contributed to the data processing infrastructure behind the sequencing of over 100,000 genomes for rare disease and cancer patients.
New professionals have joined Genomatis, bringing complementary expertise in public health, data engineering, and artificial intelligence. That collective experience revealed a critical gap: while large-scale genomic medicine had been proven viable, the technology remained inaccessible to most of the world — locked behind prohibitive costs, slow turnaround times, and fragmented infrastructure.
Genomatis exists to close that gap. We acquired deep expertise in public and private healthcare systems and in genomic data engineering and rebuilt the platform from the ground up — leveraging modern AI, cloud-native architecture, and scalable design to deliver clinical-grade genomic analysis at a single-digit percentage fraction of legacy costs for the analysis reports.
Today, our platform is enabled to process public health and genomic data for hospitals, laboratories, government health programmes, and municipalities — bringing precision medicine to populations that have never had access to it before.
Five Products. One Integrated Platform.
Each product addresses a distinct clinical and commercial need — yet all share a common data backbone, AI engine, and compliance framework. Together, they cover the full lifecycle of genomic medicine and the world's key public health demands.
Enterprise-Grade. Healthcare-Proven.
Every component of the Genomatis service groups is selected for clinical reliability, regulatory compliance, and scalability. Production-hardened technology trusted in global medicine.
AI / ML Engine
PyTorch 2.x, genomic transformer models (DNABERT-2, ESM-2), LLMs for clinical NLP (fine-tuned Llama 3, ClinicalBERT), RAG with vector search (Milvus), and MLflow for model lifecycle management.
Processing Pipeline
FastAPI async backend (Python 3.12), Apache Airflow orchestration, Apache Kafka event streaming, containerised on Kubernetes with auto-scaling. Processes 50+ TB genomic data monthly.
Data Architecture
PostgreSQL 16 (transactional), TimescaleDB (time-series), MongoDB (semi-structured genomic data), Redis (caching), Elasticsearch (search), Apache Iceberg data lake on S3-compatible storage.
Healthcare Security
AES-256-GCM encryption at rest, TLS 1.3 + mTLS in transit, field-level encryption for PII/PHI, OAuth 2.0 + OIDC, RBAC/ABAC, hardware security modules (HSM), immutable audit logs with 7+ year retention.
Global Infrastructure
Multi-region Kubernetes deployment: Americas (primary), Europe (GDPR), Asia-Pacific. 99.99% uptime SLA, <5 min RTO, <30 sec RPO, with full disaster recovery and cross-region replication.
Observability
Prometheus + Thanos (metrics), Grafana Enterprise (dashboards), OpenTelemetry + Jaeger (distributed tracing), ELK + Loki (logging), Sentry (error tracking), PagerDuty (alerting).
Serving a $41B Market Across Multiple Segments
Genomatis products address distinct segments in the public and private healthcare ecosystem, each representing billions in addressable revenue.
Hospitals & Health Systems
Clinical genomic analysis for rare disease diagnosis, oncology profiling, and pharmacogenomic testing. Replacing manual, vendor-locked workflows with an integrated cloud platform.
Up to £863K per network annuallyClinical Laboratories
High-throughput genomic analysis at scale. Laboratories performing 150,000+ genetic tests annually require platform-grade infrastructure.
Up to £1.99M per laboratory annuallyGovernment & Public Health
National genome programmes, newborn screening mandates, and municipal healthcare modernisation. Brazil's R$23B AI investment plan (Source: Ministry of Science, Technology and Innovation, 2024) creates an immediate addressable market.
Multi-year government contractsAcademic & Research Institutions
Universities, research hospitals, and biobanks conducting genomic research at scale. Federated data access and population analytics tools.
Up to £1.66M per institution annuallyBuilt for the Most Regulated Industry on Earth
Healthcare data, including genomic, is the most sensitive information in the world. Our platform is architected from the ground up for regulatory compliance — not retrofitted.
Advancing Medicine and Global Health, Together
Whether you are a hospital seeking better diagnostics, a government building a national programme, or a municipality transforming citizen healthcare — we have a solution designed for your scale.